NCT03535844

Brief Summary

This purpose of this study is to assess the impact of consuming wolfberry on cardiovascular risk in Singapore's middle-aged and older adults. The investigators hypothesize that consuming wolfberry with a healthy eating pattern diet will contribute to improvements in cardiovascular health when compared to a similar diet without wolfberry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable cardiovascular-diseases

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 24, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

August 6, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2019

Completed
6 months until next milestone

Results Posted

Study results publicly available

April 1, 2020

Completed
Last Updated

April 22, 2020

Status Verified

April 1, 2020

Enrollment Period

1.1 years

First QC Date

April 22, 2018

Results QC Date

March 6, 2020

Last Update Submit

April 13, 2020

Conditions

Keywords

Wolfberry (Goji berry)Healthy dietCardiovascular diseasesEndothelial functionLipidomicsMiddle-aged and older adultsOxidative stressInflammation

Outcome Measures

Primary Outcomes (8)

  • Change in Lipidomic Profiles

    The main classes of lipids in the cell membrane

    Pre- and post-intervention (Week 16)

  • Change in Carotid Intima Media Thickness

    Carotid intima media thickness measured using high-frequency ultrasonographic imaging

    Pre- and post-intervention (Week 16)

  • Change in Endothelial Progenitor Cells

    Quantity and quality of circulating endothelial progenitor cells

    Pre- and post-intervention (Week 16)

  • Change in Flow Mediated Dilation

    Brachial artery flow mediated dilation measured using high-frequency ultrasonographic imaging

    Pre- and post-intervention (Week 16)

  • Change in Plasma Nitric Oxide

    Concentrations of plasma total nitrate/nitrite using commercially available ELISA assay kits.

    Pre- and post-intervention (Week 16)

  • Change in Blood Carotenoid Status

    Fasting state plasma carotenoids using high performance liquid chromatography.

    Pre- and post-intervention (Week 16)

  • Change in Plasma Endothelin-1

    Concentrations of plasma endothelin-1 using commercially available ELISA assay kits.

    Pre- and post-intervention (Week 16)

  • Change in Plasma ICAM-1

    Concentrations of plasma intercellular adhesion molecule-1 using commercially available ELISA assay kits.

    Pre- and post-intervention (Week 16)

Secondary Outcomes (11)

  • Change in Blood Lipid-lipoprotein Concentrations

    Assessed at week 0, week 4, week 8, week 12 and week 16, week 0 and 16 reported

  • Change in Blood Pressure

    Assessed at week 0, week 4, week 8, week 12 and week 16, week 0 and 16 reported

  • Change in Oxidative Stress-related Biomarkers

    Pre- and post-intervention (Week 16)

  • Change in Body Composition

    Pre- and post-intervention (Week 16)

  • Change in Skin Carotenoid Status

    Assessed at week 0, week 4, week 8, week 12 and week 16, week 0 and 16 reported

  • +6 more secondary outcomes

Study Arms (2)

Wolfberry with healthy diet

EXPERIMENTAL

Each subject will be provided one-to-one dietary counselling by a research dietitian and an instruction sheet to achieve the healthy eating pattern diet. Subjects will also be provided specific instructions to cook and consume 15 g/day wolfberry as part of a mixed-meal.

Other: WolfberryOther: Healthy diet

Healthy diet

ACTIVE COMPARATOR

Each subject will be provided one-to-one dietary counselling by a research dietitian and an instruction sheet to achieve the healthy eating pattern diet.

Other: Healthy diet

Interventions

Consumption of cooked dehydrated wolfberry as part of a mixed meal.

Wolfberry with healthy diet

Compliance to a healthy diet in accordance to recommendations by the Singapore Health Promotion Board.

Healthy dietWolfberry with healthy diet

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability to give an informed consent
  • Age 50 to 75 years
  • Willing to follow the study procedures

You may not qualify if:

  • Significant change in weight (± 5% body weight) during the past 3 months
  • Allergy to wolfberry
  • Acute illness at the study baseline
  • Exercising vigorously over the past 3 months
  • Consistently following healthy eating pattern diet in the past 3 months
  • Smoking
  • Have an average weekly alcohol intake that above 21 units per week (males) and 14 units per week (females): 1 unit = 360 mL of beer; 150 mL of wine; 45 mL of distilled spirits)
  • Pregnant, lactating, or planning pregnancy in the next 6 months
  • Taking dietary supplements which may impact the outcome of interests (e.g. vitamin supplements, antioxidant supplement etc.)
  • Prescribed and taking antihypertensive/cholesterol-lowering/ type-2 diabetic medication which started less than 5 years prior to the intervention participation
  • Insufficient venous access to allow the blood collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National University of Singapaore

Singapore, 117546, Singapore

Location

National University Hospital

Singapore, 119074, Singapore

Location

Related Publications (3)

  • de Souza Zanchet MZ, Nardi GM, de Oliveira Souza Bratti L, Filippin-Monteiro FB, Locatelli C. Lycium barbarum Reduces Abdominal Fat and Improves Lipid Profile and Antioxidant Status in Patients with Metabolic Syndrome. Oxid Med Cell Longev. 2017;2017:9763210. doi: 10.1155/2017/9763210. Epub 2017 Jun 8.

    PMID: 28685012BACKGROUND
  • Cheng CY, Chung WY, Szeto YT, Benzie IF. Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial. Br J Nutr. 2005 Jan;93(1):123-30. doi: 10.1079/bjn20041284.

    PMID: 15705234BACKGROUND
  • Toh DWK, Xia X, Sutanto CN, Low JHM, Poh KK, Wang JW, Foo RS, Kim JE. Enhancing the cardiovascular protective effects of a healthy dietary pattern with wolfberry (Lycium barbarum): A randomized controlled trial. Am J Clin Nutr. 2021 Jul 1;114(1):80-89. doi: 10.1093/ajcn/nqab062.

MeSH Terms

Conditions

Cardiovascular DiseasesInflammation

Interventions

Diet, Healthy

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Limitations and Caveats

There are no limitations to this trial currently.

Results Point of Contact

Title
Dr. Kim Jung Eun
Organization
National University of Singapore

Study Officials

  • Jung Eun Kim, PhD, RD

    National University of Singapore

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 22, 2018

First Posted

May 24, 2018

Study Start

August 6, 2018

Primary Completion

September 26, 2019

Study Completion

September 26, 2019

Last Updated

April 22, 2020

Results First Posted

April 1, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Electronic copies of the data with identifiable participant information will be kept on a secure website with access limited to the principal investigator and her research staff. All data will be de-identified prior to statistical analyses

Locations